Breast cancer incidence: Decreasing trend in large tumours in women aged 50-74

Journal of Medical Screening

Volumn 24, Issue 4, 2017, Pages 189-194

  Molinié, Florence ^a   Delacour Billon, Solenne ^a   Tretarre, Brigitte ^b   Delafosse, Patricia ^c   Seradour, Brigitte ^d   Colonna, Marc ^c  

^a Cancer Registry of Loire Atlantique   (France)

^b CENTRE VAL D AURELLE   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Breast Cancer Organized screening in Bouches du Rhône ARCADES   (France)

Author keywords

Breast cancer; Incidence trends; Population based; Screening programme; Tumour size

Indexed keywords

AGE; AGED; BREAST TUMOR; CANCER STAGING; DIAGNOSTIC IMAGING; FEMALE; FRANCE; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATHOLOGY; REGISTER;

AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; FRANCE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES;

EID: 85043449898     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141316672894     Document Type: Article

References (30)

1. Paci E, Broeders M, Hofvind S, et al. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms. Cancer Epidemiol Biomarkers Prev 2014; 23: 1159-1163.
2. Løberg M, Lousdal ML, Bretthauer M, et al. Benefits and harms of mammography screening. Breast Cancer Res 2015; 17: 63.
3. Smith RA. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates. Cancer Epidemiol Biomarkers Prev 2014; 23: 1139-1146.
4. Independent UK Panel. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-1786.
5. Smith Robert A. IARC handbooks of cancer prevention: breast cancer screening. Lyon: IARC, 2002.
6. Tabár L, Gad A, Holmberg L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 325: 829-832.
7. Duffy SW, Tabar L, Vitak B, et al. The relative contributions of screendetected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003; 39: 1755-1760.
8. Norman SA, Localio AR, Zhou L, et al. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States). Cancer Causes Control 2006; 17: 921-929.
9. Tabár L, Yen AM-F, Wu WY-Y, et al. Insights from the Breast Cancer Screening Trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J 2015; 21: 13-20.
10. Foca F, Mancini S, Bucchi L, et al. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy:screening and late-stage breast cancer. Cancer 2013; 119: 2022-2028.
11. Anttila A, Sarkeala T, Hakulinen T, et al. Impacts of the Finnish service screening programme on breast cancer rates. BMC Public Health 2008; 8: 38.
12. McCann J, Stockton D and Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998; 5:42-48.
13. Swedish Organised Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007; 109: 2205-2212.
14. Helvie MA, Chang JT, Hendrick RE, et al. Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer: reduction in late-stage breast cancer. Cancer 2014; 120:2649-2656.
15. Fracheboud J, Otto SJ, van Dijck JM, et al. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004; 91: 861-867.
16. Bleyer A and Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367: 1998-2005.
17. Nederend J, Duijm LE, Voogd AC, et al. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res 2012; 14: R10.
18. Hofvind S, Sørum R and Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol Stockh Swed 2008; 47: 225-231.
19. Ministre de la Santé et de la Solidarité. Arrê té du 29 septembre 2006 relatif aux programmes de dé pistage des cancers. Available at: www.legifrance.gouv.fr/ affichTexte.do?cidTexte=JORFTEXT000000460656 (2006, accessed 12 July 2016).
20. Sobin LH, Gospodarowicz MK, Wittekind C, et al. (eds). TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell, 2010.
21. StataCorp. Stata statistical software: release 11. College Station, TX:StataCorp LP, 2009.
22. Hofvind S, Ursin G, Tretli S, et al. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program: breast CA mortality in screened women. Cancer 2013; 119: 3106-3112.
23. Molinié F, Vanier A, Woronoff AS, et al. Trends in breast cancer incidence and mortality in France 1990-2008. Breast Cancer Res Treat 2014; 147: 167-175.
24. Séradour B, Allemand H, Weill A, et al. Sustained lower rates of breast cancer incidence in France in 2007. Breast Cancer Res Treat 2010; 121: 799-800.
25. Esserman L, Shieh Y and Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009; 302: 1685-1692.
26. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012; 19(Suppl. 1): 42-56.
27. Drukker CA, Schmidt MK, Rutgers EJT, et al. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res Treat 2014; 144: 103-111.
28. Leclère B, Molinié F, Trétarre B, et al. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol 2013; 37: 544-549.
29. Viel J-F, Rymzhanova R, Fournier E, et al. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis. Cancer Epidemiol 2011; 35:521-525.
30. Seigneurin A, Exbrayat C, Labarère J, et al. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for falsepositive cases. Breast Cancer Res Treat 2011; 127: 221-228.